Davidson Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
Davidson Capital Management's IRMD Position: Q3 2026 in Review
Davidson Capital Management increased its iRadimed (IRMD) stake by 11% in Q3 2026, buying an estimated $569K and bringing the position to 63,017 shares worth $5.43M. The position accounts for 0.9% of the portfolio, ranked #36.
Davidson Capital Management first reported a position in IRMD in Q4 2025 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- Davidson Capital Management held 63,017 shares of iRadimed worth $5.43M as of Q3 2026.
- Davidson Capital Management bought 6,333 iRadimed shares in Q3 2026, an estimated $569K.
- iRadimed made up 0.9% of Davidson Capital Management's portfolio in Q3 2026, its #36 holding.
- Davidson Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 4 quarters since.
- 47 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.